a developer of ophthalmic treatments based on its mucosal penetrating product platform
Industry Biotechnology
A.I.dvisor indicates that over the last year, KALA has been loosely correlated with RIGL. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if KALA jumps, then RIGL could also see price increases.
Ticker / NAME | Correlation To KALA | 1D Price Change % | ||
---|---|---|---|---|
KALA | 100% | -1.97% | ||
RIGL - KALA | 48% Loosely correlated | +0.70% | ||
ATHE - KALA | 42% Loosely correlated | +1.72% | ||
VICP - KALA | 29% Poorly correlated | N/A | ||
MLTX - KALA | 26% Poorly correlated | -1.60% | ||
MLLCF - KALA | 23% Poorly correlated | N/A | ||
More |
Ticker / NAME | Correlation To KALA | 1D Price Change % |
---|---|---|
KALA | 100% | -1.97% |
pharmaceuticals theme (159 stocks) | 12% Poorly correlated | -1.94% |
ophthalmology theme (7 stocks) | -0% Poorly correlated | -3.29% |